Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Nifty Pharma hits 52-wk high; Wockhardt up 15%, Laurus, Lupin at new peaks
The Nifty Pharma index was quoting higher for the fifth straight trading day, surging 3.8 per cent during the period, as against 0.37 per cent gain in Nifty 50.
Q4 Results This Week: L&T, BHEL among 120-plus companies set to report numbers
From Nifty 50 names like Larsen & Toubro, Mahindra & Mahindra, Titan, Bajaj Auto, Tata Consumer, to important broader market names like BHEL, Manappuram Finance, Lupin, Petronet LNG, Urban Company, Paytm and others, these companies will be reporting their March quarter results over the course of this upcoming week.
Buy, Sell Or Hold: Lupin, IDFC First Bank, Eicher Motors, IRFC, Eternal, Coal India — Ask Profit
Ruchit Jain and Avinash Gorakshakar provided insights on these investor queries and more on NDTV Profit's Ask Profit's show.
Lupin launches dapagliflozin tablets 5 & 10 mg in US after FDA approval
Lupin stated that the product is bioequivalent to Farxiga for the indications specified in the approved labelling. Shares of Lupin Ltd ended at ₹2,332.80, up by ₹36.65, or 1.60%, on the BSE.
Stocks to Watch for April 9: TCS, Lupin, Bosch, NHPC and more
Bosch leads key India business moves as it buys Bosch Chassis, while Lupin wins USFDA nod and major firms eye growth, investments and Q4 earnings. Here are few stocks to keep an eye on ahead of Thursday's trading session.
Lupin Ltd down for fifth straight session
Lupin Ltd is quoting at Rs 2255.6, down 0.83% on the day as on 13:19 IST on the NSE. The stock jumped 17.29% in last one year as compared to a 3.17% rally in NIFTY and a 8.74% spurt in the Nifty Pharma index.
Stocks to Watch for April 2: IOCL, Varun Beverages, Lupin, Bank & Auto Stocks and more
From Indian Oil Corporation reporting a strong operational performance for FY26 to Lupin, whose arm will acquire a 43.38% stake in Multicare Pharmaceuticals Philippines, here are some stocks to watch ahead of Thursday’s trading session.
Stocks to buy or sell: From Lupin to NTPC— Ajit Mishra of Religare Broking suggests strategies for these 3 shares
Ajit Mishra of Religare Broking provides crucial insights for navigating the current tumultuous market. With the Nifty 50 experiencing declines, he highlights opportunities in stocks like Lupin and NTPC.
Lupin receives form 483 with 2 observations after US FDA inspection at Ankleshwar facility
On Friday (March 6), shares of Lupin Ltd ended at ₹2,335.55, up by ₹3.15, or 0.14%, on the BSE.
Lupin shares hit 52-week high after registering gains for six consecutive months
Lupin is on track to hit $1 billion in US sales this fiscal year. Its US revenue guidance is above $1 billion for the financial year 2027. Its margins are estimated to be between 26% - 27% for the current year and 25% for the next year as research and development (R&D) expenses rise.
Stocks to Watch for February 26: IRFC, Tata Capital, Lupin, KFin Tech and more
Tata Capital Ltd, IRFC, Lupin, KFin Technologies, Emmvee Photovoltaic Power, and Shaily Engineering Plastics announce key financial and operational updates. Here are few stocks to track ahead of Thursday's trading session.
Lupin gets US FDA nod for Brivaracetam oral solution, launches in US market
Shares of Lupin Ltd ended at ₹2,248.90, up by ₹3.80, or 0.17%, on the BSE.